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 The regenerative medicine approach of using stem cells loaded on hydrogel 
scaffolds has gained wide attention in recent years. Tissue composites made from stem 
cells embedded in hydrogels provide a minimally invasive strategy for local delivery of 
stem cells via injection, and simultaneously keep the treatment localized in a controlled 
environment provided by the scaffold. Such treatment options have been found to be 
particularly attractive in situations such as joint degeneration, including intervertebral disc 
disease. A challenge which remains to be addressed with these tissue scaffolds is the ability 
to image them post-injection into a patient. Imaging of the scaffold provides two major 
benefits; precision in the deployment of the injected scaffold and insight into the 
degradation and restructuring of the cellular environment at the treatment site. Herein is 
described a labeling method which enables imaging of a scaffold under 19F magnetic 
resonance imaging by the inclusion of a perfluorocarbon nanoemulsion. Tissue composites 
were developed from thiol-modified hyaluronic acid, perfluorocarbon imaging agent, stem 
cells, and poly (ethylene glycol) diacrylate was added to cross-link the mixture into a 
hydrogel. The formulation of the hydrogel was determined based on a possible application 
in treating intervertebral disc degeneration as it seems well-suited based on recent studies 
in the field. The utility of the imaging agent was assessed based on viability of the stem 
cell and the strength of the signal overtime. Bioluminescent signal was measured to 
determine viability of the stem cells, and 19F magnetic resonance imaging was employed 
to observe signal strength overtime. Rheology of the hydrogel was used to characterize the 
physical properties of the hydrogel. Optimal concentration of the imaging agent was 
studied through the creation of multiple hydrogel scaffolds with varying perfluorocarbon 
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concentrations. Based on the findings, there is a single optimal level of perfluorocarbon 
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1.1 Intervertebral Disc Degeneration 
A major cause of disability and retirement is lower back pain, which affects more 
than 630 million globally [1]. The global prevalence for lower back and neck pain is 
between 22-65%, with an increasing trend [2], [3]. Frequently associated with lower back 
and neck pain is intervertebral disc (IVD) degeneration. 
The IVD is a gel-like material located between vertebrae and makes up roughly 1/4 
of the spine. It is made up of two main structures; a tough outer ring known as the annulus 
fibrosus (AF) and gel-like filling known as the nucleus pulposus (NP). The AF is composed 
of highly organized type I collagen fibers to form a strong concentric ring. The NP on the 
other hand has a higher proteoglycan concentration and randomly organized type II 
collagen fibers. Proteoglycans such as aggrecan and glycosaminoglycans such as 
chondroitin sulfate found in the NP and are major contributors to the strong water affinity 
and characteristic compressibility of the IVD. Distinct cell types also regulate the 
extracellular matrix in each region; chondrocyte-like NP cells in the NP and fibroblast-like 
AF cells in the AF. Naturally, the IVD degenerates through the combined effects of aging 
of these cells as well as fragmentation of the proteoglycans and GAGs [4]. With age these 
regulating cells in the IVD become senescent and decline in number, making it difficult to 
maintain a proper matrix [5]. Wear and tear also continue to deteriorate the IVD and 
reduces its resistance to compression and overall disc height [6].  
Degeneration of the IVD may lead to other complications. Segmental instability of 
the spine due to IVD degeneration commonly results in osteophyte formation, which are 
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bone growths of the vertebrae thought to stabilize a joint through enlargement of the joint 
surface [7]. Although osteophytes can be helpful by returning lost stability, overgrowth can 
impinge on the surrounding nerves causing chronic pain. In severe cases of IVD 
degeneration, the NP may rupture out of the weakened AF, resulting in a significant IVD 
volume loss. As a result, mobility may be reduced, and the ruptured NP may impinge on 
the nerves just as the osteophytes can to cause chronic pain. 
 
1.2 Current Techniques for Treatment 
IVD degeneration is currently treated in multiple ways on a case-by-case basis. 
Surgical treatment of IVD degeneration includes discectomy with or without disc 
replacement and potentially spinal fusion [8]. Spinal fusion involves synthesis of the 
vertebrae surrounding the problematic disc to stabilize the movement and in theory limit 
the progression of the disease [9]. Despite short term alleviation of pain, there is a loss of 
mobility at the involved vertebrae, and there are many reports of adjacent segment 
degeneration and disease and recurrence of chronic pain [10]. Total disc replacement on 
the other hand attempts to restore mobility by replacing the damaged IVD with a 
replacement material. Although some reports show success in the short run, there have 
been reports of loss of mobility and ankylosis development in the long term as well as 
adjacent level disc degeneration [11-13]. Nucleus pulposus replacement is a minimally 
invasive option in which materials such as polymethylmethacrylate and silicon are injected 
in to NP through the AF. Although minimally invasive, there is concern in the migration 
of injected materials which tend to be synthetic, gel-like, and degrade mechanically over-
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time. Finally, therapeutic options exist such as intradiscal electrothermal therapy, but this 
is technically not a treatment option but a method to decrease the pain [8]. 
 
1.3 Treatment Using Stem Cell Therapy 
 Previously discussed options are all generally limited in the long-term capability of 
restoring motion and alleviating chronic pain, and there is a growing consensus for the need 
of a new therapeutic paradigm. As such, treatment of IVD degeneration through stem cell 
therapy has received widespread attention in recent years. Stem cell therapy is promising 
in regards that the stem cells applied for treatment may fully restore the function of the 
IVD. Since new healthy stem cells are being introduced, they are thought to be capable to 
proliferate and reconstruct the damaged proteoglycans and glycosaminoglycans, thereby 
completely restoring IVD to the premorbid status. Mesenchymal stem cells (MSCs) are a 
type of stem cells which have demonstrated potential to differentiate into multiple types of 
connective tissues, including those in the NP [14]. In a pilot study on humans, treatments 
with autologous bone marrow MSCs proved to be effective in improving pain and disability 
with 71% efficacy, displaying comparably favorable outcome to spinal fusion and total 
disc replacement [15]. 
 In addition to the potential benefits, stem cell treatments have shown to have some 
risks. In animal model studies of MSC treatment for IVD degeneration, stem cells were 
found in some cases to leak out of the NP and differentiate into osteocytes which formed 
bone spurs [16]. Without proper containment techniques, stem cell injection may instead 
accelerate disease progression; hence, scaffolds are employed to facilitate localization of 
MSCs within the intervertebral space.  Numerous scaffolds have been investigated such as 
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alginate, hyaluronan, silk, and many others. Of these scaffold materials, hyaluronan-based 
hydrogels stand out as a strong stem-cell scaffold candidate for IVD regeneration. These 
biocompatible hyaluronan-based (HA) hydrogels can be injected in the NP while 
mitigating the risk of leakage through the AF. Additionally, recent studies have shown that 
HA hydrogels support differentiation of MSCs into chondrocytes, which are the primary 
cell type found in cartilage and joints such as IVD [14], [17]. 
 Hyaluronan is a collective term for the physiological forms of hyaluronic acid, a 
glycosaminoglycan which constitutes the majority of the extracellular matrix [18]. Native 
and abundant in the human body, hyaluronan is a safe biocompatible material suitable for 
cell scaffolding.  Hyaluronic acid is made by linking D-glucuronic acid and N-acetyl 
glucosamine together repeatedly. Under physiological conditions it possesses sodium 
counterions, as hyaluronic acid is strongly negatively charged and hydrophilic. To better 
control the properties of the scaffold it forms, a number of derivatives have been developed; 
thiol-modified HA, tyramine-grafted HA, and glycidyl methacrylate-HA are a few that 
allow in situ cross-linking [19]. Used in conjunction with MSCs, therapeutic effects might 
be localized in the injection site, and the scaffold matrix adds IVD volume temporarily 
while the cells contribute to the complete IVD restoration. 
 
1.4 Monitoring the Tissue Scaffold 
 Imaging of the tissue scaffold is an important possibility to consider for detecting 
potential leakage from the NP. As aforementioned, cell leakage may lead to osteogenic 
differentiation of the injected stem cells, which in turn leads to the development of bone 
spurs that may impinge on the surrounding nerves. By imaging the scaffold during its 
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injection, precise localization can be ensured which are then monitored over time for leaks. 
An additional benefit is the capability of monitoring scaffold degradation. It is generally 
considered that the scaffold should gradually degrade as the tissue regenerates in order to 
support growth without limiting space for further development [20]. By making the 
scaffold imageable, progress of NP regeneration can be indirectly gauged non-invasively. 
Several methods of imaging have been explored as options to image hydrogels in 
situ. Some imaging modalities include the inclusion of image contrast agent within the 
hydrogels such as iodine and gold for X-Ray/computed tomography (CT), gadolinium for 
magnetic resonance imaging (MRI), and various fluorescent markers for fluorescence 
confocal microscopy [21]. Alternatively, certain imaging methods developed exploit 
properties of the hydrogels to obtain endogenous signal, such as Raman-based imaging of 
alginate and chemical exchange saturation effect MRI (CEST MRI) of gelatin [22], [23]. 
In this thesis another modality is described which is the use of perfluorocarbon 
nanoemulsion for 19F MRI.  
 
1.5 Overview of 19F MRI 
 19F MRI is a technique which employs the detection of resonances produced by 19F 
nuclei in a magnetic field to create images. The NMR detectable 19F nucleus has 100% 
natural abundance, and possess a gyromagnetic ratio which is the highest besides 1H; this 
results in high MRI sensitivity and allows its use for a variety of MR applications. Unlike 
the 1H nucleus, which is the typical source of signal for MRI, there is a low level of 
naturally available 19F in the human body. As such, 19F MRI allows for imaging of 
exogenous imaging agents without any background present, resulting in “hot spots” where 
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agents are located. The signal may be conveniently mapped by overlaying 19F signals onto 
1H images. Additionally, because the gyromagnetic ratio of 19F, 40.08MHz/T, is very 
similar to 1H, 42.58MHz/T it is possible to produce coils capable of detecting both nuclei 
either by retuning between scans or having double resonance circuits. Other nuclei will be 
more complicated to use for hot spot imaging due to sensitivity challenges or requirements 
for hyperpolarization equipment [24]. An additional benefit of having similar NMR 
characteristics is that most sequences used in 1H have been adapted to 19F and will use the 
same transmit and receive hardware on the scanners. Fast imaging methods used in 1H 
scans such as fast low angle shot (FLASH), fast low angle rapid acquisition with relaxation 
enhancement (FLARE), rapid acquisition with relaxation enhancement (RARE) all exist 
for 19F and can easily be applied with only slight modifications to the original pulse 
sequences [25], [26]. 
Currently, 19F MRI finds itself used in a variety of applications including  
inflammation imaging, stem cell tracking, lung imaging, and monitoring of drug-delivery 
[27]–[30]. Cell tracking is possible through the cellular absorption of highly inert fluorine 
nanoemulsions while lung imaging employs inert fluorinated gases and monitoring of drug 
delivery employs nanocarriers which include fluorine in their formulation. Cell tracking is 
particularly challenged by the limited amount of 19F which can be taken up by cells, 
resulting in relatively low detection sensitivity. In contrast to direct internalization of 
fluorine by cells, hydrogels can be labelled with much higher quantities of fluorine, which 
increases their detectability by MRI. Here a nanoemulsion, which is made by emulsifying 
perfluorocarbons, was integrated into the hydrogels to provide an exogenous signal to map 
the tissue composite. Other methods which directly fluorinate the cell scaffold have been 
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attempted previously, for example fluorination of polyurethane was performed by 
Lammers et al. [31]. The method here is simpler, and the result is sharp 19F resonance 
which can be readily and sensitively detected. 
Use of 19F imaging agents can sometimes be advantageous compared to 1H contrast 
agents based on gadolinium, manganese, or super paramagnetic iron oxides which reduce 
local 1H2O (water) relaxation times and thereby alter the water signal. Signal changes 
produced by these contrast agents are sometimes challenging to differentiate from changes 
produced by biological events such as infection, hemorrhage or other sources, which can 
be problematic [32]. Obtaining favorable MR images also generally requires large amounts 
of contrast agent due to low polarization of 1H2O in a magnetic field, and injections of large 
volume of heavy metals such as gadolinium may lead to adverse events such as 
Nephrogenic Systemic Fibrosis [33]. Perfluorocarbons are well tolerated at high doses and 
have been used as blood substitutes [34].  
 Despite these advantages, 19F MRI still has limitations to overcome. The main 
problem with 19F MRI is the much lower spatial resolution compared to that of a 1H scan. 
This is largely due to the relatively low quantity of fluorine injected compared to the ~110 
M water in biological tissue, which results in a diminished signal to noise ratio (SNR) 
compared to a 1H scan [35]. The reception of the 19F detection coil is also a factor. Due to 
this, single-frequency-mode RF coils are often used to maximize SNR, which requires coil 
swapping or retuning. Additional time for imaging is thus required, and the extra motion 
can also affect the co-registration process of mapping the 19F to the 1H scan. Auto-tuning 
RF coils and dual-mode RF coils exist, but they are not particularly prevalent, particularly 
in the clinical setting, due to the increased complexity and cost required. Some of these 
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problems are currently being addressed though, such as the development of cryogenic RF 
coils with high SNR by a research group in Charité University [36]. With the advancement 
of 19F MRI technology and the presence of a wide variety of fluorine drugs and 
applications, 19F MRI technique remains promising with respect to clinical applications in 





2 Experimental Methods for Fluorine Hydrogel 
 
2.1 Materials 
 To assess the efficacy of perfluorocarbon as an imaging agent, the rheological effect 
on hydrogels, viability of the cells co-residing in the hydrogels, and the capability to image 
over-time were measured. The perfluorocarbon nanoemulsion used was VS-1000H 
(Celsense, Inc., PA 15222), a pre-clinical grade emulsion of perfluoro crown ether in 
clinical grade water for injection. The scaffold material was constructed using thiol-
modified hyaluronan (Glycosil®, ESIBIO, Alameda, CA 94501) and a thiol-reactive 
PEGDA crosslinker (Extralink®, ESIBIO) that has a molecular weight of 3400 Da. Both 
the thiol-modified hyaluronan and the thiol-reactive cross-linker were desiccated with PBS 
salts such that when reconstituted according to the manufacturer’s protocols, they were 1% 
wt./vol. in 1x PBS. The structures of the hyaluronan and PEGDA can be seen in Figure 1 
and Figure 2. The PEGDA is used to cross- link the thiol-modified hyaluronan, although it 
is noted that the hyaluronan can cross-link between itself at a much slower rate in the 




2.2 Cell Culture  
Stem cells used in the tissue scaffold were mesenchymal stem cells (MSCs) with 
luciferase expression which were derived from the bone marrow of luciferase expressing 
transgenic FVB mice. To obtain the stem cells, the femurs and tibia were removed from 
the mice, and cells were flushed out using a needle and 1x PBS. All cells flushed out were 
then collected and centrifuged. The resulting cell pellet was reconstituted using culture 
media and seeded in a T-75 polystyrene flask. The culture media used was composed of 
Dulbecco’s Modified Eagle’s Medium (Gibco®), 10 % volume of fetal bovine serum 
(Gibco®), 1% volume of antibiotics (10,000U/mL penicillin and 10mg/mL streptomycin). 
Figure 2: Structure of Poly (ethylene glycol) diacrylate or PEGDA. 
PEGDA is important in cross-linking of the thiol-modified hyaluronan 
into a hydrogel. 
Figure 1: Structure of thiol-modified hyaluronan. The thiol-modification is depicted as 
a hanging structure on the top of the figure. Thiolation of hyaluronan allows 
hyaluronan, which otherwise cannot gelate, to form a hydrogel. 
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Hematopoietic cells and other non-MSCs were removed through selective culturing, and 
after the second round of passaging the phenotype in the flask was observed to be 
homogenous. 
 
2.3 Hydrogel Preparation 
 Hydrogels were formed with the following components: thiol-modified hyaluronic 
acid (HA), PEGDA, VS-1000H (VS), and MSCs. 4 different concentrations of VS were 
tested to study its impact on the gels. First the HA and PEGDA were reconstituted 
accordingly to the manufacturer’s protocol from its powder form to 1% wt./vol using 
degassed water. VS was subsequently added at varying ratios to HA creating 4 groups: 1:0 
HA:VS (no VS), 50:1, 10:1, 5:1, and 1:1. MSCs were detached from the cell culture flask 
through trypsinization and centrifuged. The cells were then resuspended to a concentration 
of 2x107 cells/mL in cell culture media and added to the hydrogel mixture to make up 7.4% 
of the final hydrogel volume which equates to ~1.5 million MSC/mL of hydrogel. Cross-
linking was then initiated by adding PEGDA at a ratio of 4 HA to 1 PEGDA by volume. 
The mixture was then pipetted carefully until a homogenous hydrogel was formed. The 1:1 
hydrogel did not form a stable hydrogel due to the lowered concentration of HA; therefore, 
this hydrogel formulation is not discussed henceforth. 
 
2.4 Rheology 
A rheological study of the hydrogels was performed to obtain the stiffness (storage 
modulus) and the gelation kinetic of the hydrogels. Measurements were made on an ARES-
G2 rotational rheometer (TA Instruments, New Castle, DE 19720). The gelation kinetics 
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for the hydrogel was studied using a 25mm flat plate geometry, and the environment was 
set to 37°C with controlled humidity using Peltier solvent trap and evaporation blocker. 
The storage modulus was measured for 1 hour using a step time of 8s at a rotational 
frequency of 1Hz with an oscillation strain of 1±0.02%. Measurements were recorded 
promptly after mixing the proper ratios of hyaluronan, PEGDA, and VS-1000H. 
 
2.5 Cell Viability 
In Vitro 
The viability of MSCs was determined for each type of hydrogels. Preparation of 
the hydrogels was done by mixing the contents in a 1.5mL conical Eppendorf tube using a 
pipette. Each type of hydrogel was then seeded as triplicates of 50μL volume onto a flat 
bottom 96-well plate for a grand total of 12 wells. The viability was measured through 
bioluminescent signals of the MSCs using Victor3 Multilabel Microplate Reader 
(PerkinElmer). Prior to imaging, a stock 30mg/ml D-luciferin (D-Luciferin, Potassium 
Salt, GOLD BIOTECHNOLOGY, Inc., St. Louis, MO) solution in PBS was mixed with 
cell culture media to create 0.2mg/mL dilution. Media from the cell culture plate was 
aspirated carefully and replaced with 100µL of 0.2mg/mL D-luciferin solution using a 
multi-channel pipette. The plate reader was set to 37°C, and each well was imaged with 3s 
exposure and measurement of the plate repeated until a peak signal was observed. 
 
In Vivo 
The viability of the MSCs injected within the scaffold was observed in mice. Prior 
to hydrogel injection, the mice were prepared for injection and bioluminescent imaging by 
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shaving and application of Nair for complete hair removal on the back. Preparation of the 
hydrogel was done through a mixture of the contents in a 1.5mL conical Eppendorf tube. 
As the gelation time approached, the hydrogel was loaded on to a 27-gauge 1mL syringe. 
The hydrogel was injected in 50μL volumes subcutaneously on the dorsal side along the 
left and right sides of the spine. Injections were done in triplicates where each group of the 
same hydrogel was injected columnar down the spine, totaling 6 injections per mice. The 
mice used were RAG2 KO (B6(Cg)-Rag2 tm1.1Cgn/J, The Jackson Laboratory) and 
were 3 months old. 
Prior to imaging, 150μL of 30mg/ml D-luciferin solution in PBS was injected into 
each mouse intraperitoneally. The mice were then put under gas anesthesia with 2.5% 
isoflurane and imaged for bioluminescence using IVIS Spectrum (PerkinElmer) optical 
imaging device after 1 day and then weekly. 
 
2.6 19F MR Imaging  
In Vitro 
Imaging of hydrogel phantoms with perfluorocarbon agent was studied. First, 
100μL volume hydrogels were formed in 0.5mL conical polypropylene tube with the same 
formulation as aforementioned in section 2.3, but without the addition of the cell 
suspension. Two of each hydrogel types containing VS was created and one hydrogel 
without VS. 100μL of 1xPBS was added above the formed hydrogel to prevent its 
dehydration. The PBS was replaced every other day as a parallel to the in vitro viability 
study where the cell culture media was replaced every other day. 
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Imaging was performed on a vertical bore 17.6T scanner (Bruker Avance 750 WB), 
using a 1H/19F dual-mode volume coil. 1H images were acquired at 750MHz and 19F images 
at 705.5MHz. 1H images were acquired using rapid acquisition with relaxation 
enhancement (RARE) sequence with the following parameters: echo time (TE) = 6.260ms, 
Rare Factor = 8, Repetition Time = 2500.000ms, Number of Average (NA) = 1, Spatial 
Resolution = 0.1953125mm x 0.1953125mm, FOV = 25mm x 25mm. 19F image were 
acquired with a modified RARE sequence with the following parameters: TE = 5.79ms, 
Rare Factor = 8, Repetition Time = 1000ms, NA = 32, Spatial Resolution = 0.78125mm x 
0.78125mm, FOV = 25mm x 25mm. The phantoms were imaged for 12 weeks. A reference 
glass capillary tube with VS was included to use as a reference for intensity comparison. 




 The same mice from the cell viability study was used for 19F MRI. Mice were 
sedated using ketamine/xylazine cocktail (100mg/kg, 10mg/kg), and subsequently imaged 
using the same coil and imaging parameters as the in vitro study. A reference glass capillary 
tube containing VS was placed on the ventral side of the mice. Signal intensity of the 




3 Experimental Results 
 
3.1 Rheology 
The storage modulus of all hydrogel formulations is presented in Figure 3. From 
the figure it is evident that the gelation is delayed by the addition of VS to the hydrogel. 
Additionally, the plateau of the exponential increase in storage modulus is lower as the VS 
concentration increases, showing that VS plays a role in lowering the overall storage 
modulus or stiffness of the hydrogel. The results also indicate that the 50:1 addition of VS 
is too low of a concentration to affect the rheology of the hydrogel. 
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3.2 Cell Viability 
In Vitro 
The longitudinal BLI study of the in vitro experiment is shown in Figure 4. Initially, 
there was a strong variability in the BLI signals between the hydrogel samples with 5:1 
hydrogel having a much stronger signal compared to the other hydrogels. On day 3, there 
was a sharp attenuation in signal strength and followed by another period of strong signal 
on day 7. This trend of fluctuation continued until the fluctuation seemed to damp out 
around week 6, and by week 8 the signal strength from strongest to weakest was 
consistently 5:1, 10:1, 50:1, and 1:0. This indicates that VS has a positive effect on the 



















Time Course Storage Modulus of Different 
Hydrogels
1:0  HA:VS
50:1   "
10:1   "
5:1     "
Figure 3: Rheometric measurement of the in situ hybridization of hyaluronan hydrogels using 
ARES-G2 rotational rheometer. Storage modulus of the hydrogel as it gelates is plotted against 
time. The points shown are in step time of 8s, and some negative readings were omitted in the 
logarithmic depiction of the data. 
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The bar for 1:0 in Figure 4 shows that out of the triplicates measured, one of the wells 
consistently had baseline level signals. This indicates that the cells in this well was not 
viable from the start although the reason is not clear. The graph seems to indicate that the 
1:0 hydrogel would have had comparable signal to that of the 50:1 gel up until day 35, at 
which point the signal fluctuation seemed to dampen as the other hydrogel types, albeit at 
a lower final signal strength. 
 
In Vivo 
 A sample BLI measurement of mice can be seen in Figure 5. The heat map of the 
BLI signal was generated using Living Image software. Equal sized region of interests 
Figure 4: Overtime BLI measurements of tissue scaffold in vitro. The 96 well-plate containing 
MSCs in hydrogel was imaged for 11 weeks. 
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(ROIs) were selected on the heat map over the 12 injections, and the signal strength 
overtime is plotted in Figure 6. Initial signal was strongest for the 10:1 gel, followed by the 
5:1 gel, and lowest signal between 1:0 and 50:1. The similarity of the 50:1 to the 1:0 
suggests that the low level of V-sense is not enough to contribute any noticeable effects to 
the cell viability. Viability decreased for all gels over the course of 4 weeks but at the last 
week, there were signs of signal recovery in the 10:1 gel suggesting some proliferation and 
remaining viable cells. There is also a similar trend here as the in vitro measurements where 
there is a high initial standard deviation for higher VS concentration gels. VS seems to add 
an element of unpredictability to cell viability; however, in all cases it is seen that the 
deviations between the samples decline overtime, mainly due to the decline in overall 
signal. Here we determined that the 10:1 gel is most promising for injection based on the 





Figure 5: BLI signal heatmap generated using Living Image software. The measurement is from 3 
weeks post injection of the tissue scaffold. Variability in the heatmap can be seen between the 
injection sites, but they are generally on the same order within each column of injection. 
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3.3 19F MR Imaging 
In Vitro 
Measurements of the phantoms were performed overtime on a weekly basis to track 
the signal strength of fluorine. Typical MRI images produced can be seen in Figure 7. The 
image was processed using ImageJ; 19F signal is represented using color map hot, 1H signal 
is represented using grayscale, and low-signal noise was filtered. The signal strength is as 
expected with the highest VS concentration (5:1) phantom having the strongest signal 
intensity followed by 10:1 then 50:1. The control phantom here is the 1:0 hydrogel which 
contains no fluorine and thus has no observable 19F signal. The reference placed along the 
phantom is pure VS in capillary used to interpolate the intensity of the phantoms over time. 
The longitudinal signal intensity change can be seen in Figure 8. The signal intensity in 
units of procedure defined unit (p.d.u.) is shown in the graph. To make qualitative 










































Figure 6: Overtime in vivo measurements of BLI signal from injected MSCs in hydrogel. ROI 
from the BLI image was analyzed weekly and plotted. The data represents the mean of 3 




measurements, the reference signal was used to assign values to the signal intensity of the 
hydrogel phantom. From the figure it is evident that after 1 week from the hydrogel 
creation, the 10:1 and 50:1 hydrogels retained their fluorine content well. On the other 
hand, the 5:1 hydrogel lost signal overtime suggesting that the lowered concentration of 
hyaluronan relative to VS allowed VS to escape out of the scaffold. Again, the 10:1 
formulation seems to be the best as it maintains strong signal without sacrificing much of 
its imaging stability as the 5:1 hydrogel did.   
  
Figure 7: 19F image overlay (shown in red) on 1H image (shown in grayscale). 
A) Day 1 after phantom creation, B) 10 weeks after phantom creation. The 
reference location changed slightly over each imaging session, but the 
reference and its fluorine content remained the same. 
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Figure 8: Plot of the signal intensity of hydrogel phantoms measured overtime. Signal intensity 
was measured in procedure defined units measured from the relative intensity to a reference signal. 
The calculations were performed on Voxel Tracker 2.0. After an initial signal decrease from Day 
1 to Day 7 signal strength was relatively constant for the 10:1 and 50:1 hydrogel. The 5:1 hydrogel 
had a continuous drop in signal, although even after 12 weeks the signal remained stronger than 
the 10:1 hydrogel. 
In Vivo 
 1H/19F T2-weighted images of mice were acquired using RARE sequence. A typical 
image obtained from the process can be seen in Figure 9. 5:1 and 10:1 hydrogels emit a 
strong signal which can be clearly visualized, while the 50:1 remains difficult to detect. In 
certain time points, 50:1 hydrogels did not produce strong enough signal to be detectable 
post-processing for low signal-noise removal. Signal strength overtime is shown in Figure 
10. Based on the graph it is clear that the 50:1 formulation does not contain adequate levels 
of fluorine for imaging. The signal was below background levels and not detectable on 
weeks 2 and 8. As for the 5:1 and 10:1 hydrogels, their signal was continuously detectable. 
Due to the susceptibility of the signal to noise and changes in coil receptivity, it is difficult 
to make absolute statements about what is the minimum detectable threshold; however, the 
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week 3 image contained one of the weakest signal for the 10:1 hydrogel but as seen in 
Figure 9, the 10:1 signal is clearly visible. 
 
Figure 9: MRI image of a mouse 2weeks post-injection. Cross-section of the mice are 
shown to visualize the origin of the 19F signal. It is evident from the image that the 
reference signal is displayed with equal intensity in both images, allowing for a visual 
comparison of the two. The 50:1 signal is much weaker than the 5:1 and 10:1 signals, 
and the 1:0 is not detectable with 19F MRI as expected. 
Figure 10: Signal intensity of injected tissue scaffolds overtime. Intensity is in procedure defined 
unit calculated based on the signal intensity relative to the reference signal in the MR image. Week 




The results obtained show that the use of perfluorocarbon nanoemulsions is a 
promising image labeling strategy for tissue composites. We have found only one study of 
19F injectable tissue composite labeling, and one long-term cytotoxicity study of a clinically 
non-relevant method of imaging using fluorescent quantum dots used in silk-based 
scaffold, but the imaging tracer was found to lose signal nearly 10 times the rate found here 
and proved to be cytotoxic [37].  
Other groups using a poly(L-glutamic acid)-graft- tyramine/poly(ethylene glycol) 
hydrogel, which have similar rheological characteristics to the hyaluronan hydrogel here, 
found that cell viability was increased for hydrogels loaded with increased amount of 
therapeutics [38]. The authors suggested that increased gaps in the cross-linked network of 
the hydrogel may produce this effect, which seems similar to the results found here, where 
increased VS led to better viability. Other methods which attempted MRI tracking through 
cell-based labelling rather than labeling the hydrogels itself found that there is signal 
intensity dilution as the cells proliferated and migrated [39]. Although this is not 
necessarily a negative feature, the application to IVD regeneration may be limited due to 
the sparse cell placement in the IVD and the requirement to monitor for leakage would 
likely need a higher concentration of image contrast agent which is easier done by 
incorporating into the scaffold instead of cells. Still there are many other options, such as 
chemical immobilization of the imaging agent to the scaffold, where incorporation of such 




The rheological measurements made during the in situ hybridization clearly show 
that VS plays a role in lowering the stiffness of the hydrogel. From the BLI measurements 
it is also evident that VS enhances cell viability. It is thus difficult to attribute what exact 
property(ies) of VS contributes to the enhanced cell viability, but there are some theories 
to explain this phenomenon. One possibility is that the cell viability is affected by the 
storage modulus of the hydrogel it is in. The hydrogel storage modulus is correlated to the 
degree of cross-linking between the hyaluronan, and as the storage modulus decreases the 
diffusion of nutrients to the cells maybe enhanced. The lowered cross-linking may also 
provide more space for cell proliferation and development of its own extracellular matrix 
which would lead to better cell survival overtime. Another possibility is due to the gas 
dissolving properties of VS, or perfluorocarbons in general. Perfluorocarbons have a high 
gas solubility due to the weak intermolecular forces between themselves, and some 
perfluorocarbons such as perfluoromethylcyclohexane can have over 300 times the 
solubility of nitrogen gas compared to water [41]. The increase in gas solubility would 
allow oxygen to be more readily available to nearby cells which would also keep them 
viable for longer periods. The oxygen may also play a role in speeding up the 
bioluminescence reaction. Equations (1) and (2) show part of the light emitting reaction of 
luciferin, and it shows that oxygen is required to produce light [42]: 
𝑙𝑢𝑐𝑖𝑓𝑒𝑟𝑖𝑛 + 𝐴𝑇𝑃 + 𝐸𝑛𝑧𝑦𝑚𝑒
𝑀𝑔2+
→   𝐸𝑛𝑧𝑦𝑚𝑒 𝑏𝑜𝑢𝑛𝑑 𝑙𝑢𝑐𝑖𝑓𝑒𝑟𝑦𝑙 𝑎𝑑𝑒𝑛𝑦𝑙𝑎𝑡𝑒 + 𝑃ℎ𝑜𝑠𝑝ℎ𝑎𝑡𝑒… (1)  
𝐸𝑛𝑧𝑦𝑚𝑒 𝑏𝑜𝑢𝑛𝑑 𝑙𝑢𝑐𝑖𝑓𝑒𝑟𝑦𝑙 𝑎𝑑𝑒𝑛𝑦𝑙𝑎𝑡𝑒 + 𝑂2 → 𝑑𝑒ℎ𝑦𝑑𝑟𝑜𝑙𝑢𝑓𝑐𝑖𝑓𝑒𝑟𝑖𝑛 + 𝐸𝑛𝑧𝑦𝑚𝑒 + 𝐶𝑂2 + 𝐴𝑀𝑃 + 𝑙𝑖𝑔ℎ𝑡  
…(2) 
By providing more oxygen, ATP production for step 1 and conversion of enzyme-bound 
luciferyl adenylate may occur at a more rapid pace leading to increased bioluminescence 
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in a given time frame. In such a manner, VS may provide the capability to increase 
bioluminescence which was interpreted as a higher viability in the hydrogel. 
 In the in vivo MRI, a fluctuation in signal intensity was detected. After the 
experiments were conducted, it was later determined that the primary cause of the 
fluctuation was due to the change in the reference signal. In the vertical bore of the MRI, 
the VS in the reference capillary tube slowly separated with the dense perfluorocarbon 
nanoemulsions slowly settling. This occurred partly due to the degradation of VS 
emulsions over time, allowing the perfluorocarbons to settle to the bottom. The differences 
in reference concentration overtime caused a false drop in signal for the week 2 and week 
3 measurements as the condensed reference and the implanted hydrogels were compared. 
Post week 3 this was accounted for and a fresh set of stable VS was used for each round of 
measurement. A lesser cause of these fluctuations was due to inevitable systematic errors 
between imaging sessions. Mice were not imaged at exactly the same location every single 
time leading to minor differences in read out. This problem was mitigated by the usage of 
a thin slice geometry to sample the cross section of the mice at a higher geometric 
frequency. 
 Despite the in vivo MRI having issues of calibration, the in vitro results seem to be 
in a stable condition. Despite the steady decrease in signal intensity of the 5:1 hydrogel, it 
is evident that the rest of the hydrogels do not follow this trend. In fact, the signal increases, 
were likely due to hydrogel shrinkage or unavoidable systematic errors in the imaging such 
as field homogeneity, variations in tuning, and many other possible causes. As the signal 
slightly increases in the other two, the drop of signal in the 5:1 cannot be attributed to 
sedimentation of the VS emulsions in the reference capillary. Additionally, the imaging of 
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the in vitro phantoms was conducted before the in vivo measurements, and thus likely that 
the VS was in a more stable condition. 
 To clarify the cause of enhanced cell viability when VS is added to the hydrogel 
scaffold, more tests need to be performed. A production of hydrogel diluted simply with 
clinical water for injection, which the perfluorocarbon was suspended in, in the same ratio 
as the VS (1:0, 50:1, 10:1, and 5:1) would allow to see if dilution of hyaluronan was a key 
factor in improving cell viability. If the lowered hyaluronan concentration is indeed the 
contributing factor to improvement of cell viability, a comparison can be made to see if the 
VS emulsion has different effects on cell viability compared to water. Next, to test if VS 
speeds up bioluminescence to produce an erroneously high cell viability measurement, VS 
can be added to the luciferin solution to see whether the bioluminescence signal shows up 
brighter and achieves a peak signal earlier. Determining the validity of bioluminescence 
when measured in the presence of VS means cell viability will not be required to be tested 
in an alternative method. 
If BLI measurements are invalid, another form of viability test which avoids the 
use of metabolic activity would be preferred such as a DNA/nuclei binding fluorescent 
marker. Such markers will allow viability tests independent from the oxygen level in the 
hydrogel. Such viability tests were not optimal for an overtime experiment conducted here, 
as the fluorescent markers generally have a very specific incubation time assuming it is in 
direct contact with the cells; in hydrogels, the fluorescent markers must be diffused in 
through the hydrogels and into the cells then subsequently washed out of the hydrogel 
scaffold for an accurate reading which is impossible. Measuring in this method, will 
therefore require the use of a detergent such as hyaluronidase to digest the hyaluronan 
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scaffold and to subsequently collect the cells through centrifugation to tag with fluorescent 
markers. Secondly, in vivo measurements would be orders of magnitude more difficult 
provided that the implanted hydrogels much be excised and the native tissue/cells somehow 
removed before the digestion of the scaffold.  
4.2 Conclusions 
Hydrogels with physically immobilized perfluorocarbon allows imaging of the 
injected tissue composite for a long time. As these particles were not found cytotoxic either, 
tissue composites with these particles embedded may be functional in clinical application. 
Next steps to take would require a study of the differentiation of MSCs cultured into these 
scaffolds. Checking if perfluorocarbon inhibits chondrogenic differentiation or promotes 
some other differentiation pathway should be studied in order to ensure its proper 
application. Effects of differences in 3D culture conditions also remain to be studied; the 
differences in culturing a thin sheet of tissue composites on a well-plate against a much 
larger volume similar to what would be used clinically may provide significant differences 
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